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A b s t r a c t
Background: The issue of self-perceived health control and related sense of self-efficacy has not received any attention in 
patients with heart failure (HF), although these psychological features have been established to determine the patients’ ap-
proach towards healthcare professionals and their recommendations, which strongly affects compliance.
Methods: A total of 758 patients with systolic HF (age: 64 ± 11 years, men: 79%, NYHA class III–IV: 40%, ischaemic aetiol-
ogy: 61%) were included in a prospective Polish multicentre Caps-Lock-HF study. A Multidimensional Health Locus of Control 
(MHLC) scale was used to assess subjective perception of health control in three dimensions (internal control, external control 
by the others, and by chance); the Generalised Self Efficacy scale (GSES) was used to estimate subjective sense of self-efficacy; 
and the Beck Depression Inventory (BDI) was used to determine depressive symptoms.
Results: The majority of patients perceived the external control (by the others) and internal control of their health as high (77% 
and 63%, respectively) or moderate (22% and 36%, respectively), whereas self-efficacy was perceived as high or moderate 
(63% and 27%), which was homogenous across the whole spectrum of the HF cohort, being unrelated to HF severity, HF 
duration, the presence of co-morbidities, and the applied treatment. The stronger the perception of internal health control, 
the higher the self-efficacy (p < 0.05); both features were related to less pronounced depressive symptoms (p < 0.05).
Conclusions: The established pattern of self-perceived control of own health and self-efficacy indicates that patients with 
HF acknowledge the role of others (i.e. healthcare providers) and themselves in the process of the management of HF, and 
are convinced about the high efficacy of their undertaken efforts. Such evidence supports implementation of a partnership 
model of specialists’ care of patients with HF.
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INTRODUCTION
Chronic disease with severe persistent symptoms and grave 
prognosis has a profound impact on the patient’s psychological 
status [1]. The individual psychological features of each patient 
determine the approach towards the administered diagnostic 
and therapeutic interventions, which affects compliance [2–4] 
and the effectiveness of treatment of such a patient [5]. 
Oncology is an example of a medical specialty in which 
comprehensive clinical assessment of a patient compromises 
the psychological examination [6], which allows the imple-
mentation of psychological interventions aimed at strengthen-
ing certain features, which could be beneficial in the context 
of a struggle with severe long-lasting disease [7]. Healthcare 
professionals (physicians, nurses, physiotherapists, and psy-
chotherapists) adjust their approach to a patient respective to 
his/her psychological status, which improves the effectiveness 
of medical care [8]. 
The diagnosis of heart failure (HF), similarly to cancer 
disease, is associated with the administration of lifelong phar-
macotherapy, frequent implementation of invasive diagnostic 
and therapeutic procedures and frequent hospitalisations 
[9], which affects daily functioning of patients with HF, and 
worsens their quality of life [10]. However, because measuring 
quality of life and depressive symptoms is still not enough for 
comprehensive assessment of a broad range of psychological 
features [11], we decided to perform a multicentre prospec-
tive study in order to investigate personal beliefs regarding 
control over patients’ own health and the subjective sense of 
self-efficacy in patients with systolic HF.
METHODS
Study population 
The study included patients hospitalised or visiting outpa-
tient clinics in 11 cardiology centres in Poland between 
September 2012 and March 2013 (one in Wroclaw, Lublin, 
Lodz, Bialystok, and Krakow, two in Warsaw, and four in 
Katowice) fulfilling the following inclusion criteria: (a) more 
than six-month documented history of HF (New York Heart 
Association [NYHA] I–IV classes [10]); (b) clinical stability 
with unchanged medications for ≥ three months preceding 
the study; (c) left ventricular ejection fraction (LVEF) < 45%. 
Exclusion criteria comprised: (a) HF decompensation within 
three months preceding the study; (b) acute coronary syn-
drome and/or coronary revascularisation during six months 
preceding the study; (c) any psychiatric abnormalities and 
associated therapy either at the time of examination or in 
the past.
The study was approved by the local ethics committee at 
the coordinating centre (WROC), which gave permission to 
conduct the study in the other participating centres. All sub-
jects gave written informed consent. The study was conducted 
in accordance with the Helsinki Declaration.
Study protocol 
Psychological questionnaires were given to each patient dur-
ing his/her hospital stay or during his/her visit in an outpatient 
clinic. Clinical data were collected from medical records. The 
following parameters were analysed: basic demographic and 
anthropometric data: age (years), gender, body height and 
mass (analysed as calculated body mass index [BMI], kg/m2); 
resting heart rate (bpm), and systolic and diastolic blood 
pressure (mm Hg); parameters reflecting the severity of HF: 
number of years since the initial diagnosis of HF, NYHA class, 
and HF aetiology; LVEF (%) derived from standard transtho-
racic echocardiography; basic laboratory parameters: sodium 
(mmol/L), haemoglobin (g/dL), and glomerular filtration rate 
(GFR, mL/min/1.73 m2) calculated using the Modification 
of Diet in Renal Disease equation; the presence of the fol-
lowing co-morbidities: myocardial infarction, hypertension, 
atrial fibrillation, stroke and/or transient ischaemic attack, 
diabetes mellitus, chronic kidney disease, anaemia, chronic 
obstructive pulmonary disease, and cancer; information about 
administered drugs (angiotensin converting enzyme inhibitors 
[ACEI] and/or angiotensin receptor blocker  [ARB], aldosterone 
antagonists, beta-blockers, loop diuretics, thiazide diuretics, 
statins, antiplatelet drugs, and digoxin), implanted devices 
(implantable cardioverter-defibrillators, cardiac resynchroni-
sation therapy or other type of pacemaker), and previously 
performed revascularisation procedures (e.g. percutaneous 
coronary intervention or coronary artery bypass graft). 
Psychological evaluation was based on standardised ques-
tionnaires. The set of psychological questionnaires (all Polish, 
officially adapted and psychometrically validated versions) 
included: Multidimensional Health Locus of Control (MHLC) 
Scale; Generalised Self Efficacy Scale (GSES); modified Mental 
Adjustment to Cancer Scale (modified Mini-MAC); Coping 
Inventory for Stressful Situations (CISS); and Beck Depres-
sion Inventory (BDI). In the current paper we report results 
obtained from MHLC, GSES, and BDI.
The Polish version of MHLC (adapted and validated by 
Juczynski, 2009) [12] was used in order to assess the health 
locus of control, which refers to personal beliefs regarding 
the control of individual health status based on three possi-
ble localisations of health control: ‘internal’ or two ‘external’ 
localisations. Patients with high scores within the subscale 
assessing an ‘internal localisation’ are convinced that their 
health status depends only on their own behaviours. Patients 
who believe that their individual health status is a conse-
quence of the actions performed by ‘powerful people’, e.g. 
doctors, family members, and friends, have high levels of 
‘external control (by the others)’. Those who believe that 
mainly chance, fate, or luck determine their health status 
would have high scores on the second subscale, measuring 
external control, named ‘external control (by chance)’. Each 
MHLC subscale is composed of six items. The answers for 
www.kardiologiapolska.pl
Agnieszka E. Siennicka et al.
170
each item are expressed using a six-point Likert scale, where 
the lowest score (1 point) means ‘strongly disagree’, and the 
highest score (6 points) means ‘strongly agree’, thus it is pos-
sible to obtain from 6 to 36 points in each subscale. There 
is no global sum/result expressing a certain general level of 
health control [12]. Moreover, a high score within one subscale 
does not exclude the possibility of having high scores also in 
other subscales. Scores in MHLC as continuous variables are 
presented in Tables 2 and 3. Moreover, we calculated the 
score of each patient in all three subscales and assigned each 
score to the following categories defined arbitrary by us: ‘low’ 
0–33.3% of the maximum score, ‘moderate’ 33.4–66.6% of 
the maximum score, or ‘high’ 66.7–100% of the maximum 
score (in each subscale). Afterwards we calculated the per-
centage of patients localised in the particular categories of all 
three types of control. The percentages were demonstrated as 
cubes (the volume of each cube was equal to the calculated 
percentage) placed in a three-dimensional graph according 
to the particular categories of health control. The results ob-
tained using this approach (scores in MHLC assigned to three 
categories) are presented on the Figure 1.
Polish version of GSES (adapted and psychometrically 
validated also by Juczynski [12]) was applied in order to 
measure the sense of self-efficacy, i.e. the conviction of an 
individual regarding his/her own competence in complet-
ing tasks (by means of behaviours, thoughts, emotions) and 
reaching desired goals. GSES includes ten items, answered 
with a four-point Likert type scale (1, 2, 3, and 4 mean ‘no’, 
‘rather no’, ‘rather yes’, and ‘yes’, respectively) [12].
Each patient also completed a BDI (version Ia) [13], 
a self-administered 21-item self-report inventory, which al-
lows differentiation of cognitive-affective (based on the first 
13 items) and somatic (based on the remaining eight items) de-
pressive symptoms. BDI total score ≤ 10 points was interpreted 
as no depressive symptoms, whereas BDI score ≥ 14 suggested 
the presence of at least mild depressive symptoms [13]. 
Statistical analyses
Normally distributed continuous variables were presented 
as means ± standard deviations (SD). The differences were 
tested using the student’s t-test or ANOVA, where appropri-
ate. Variables with a skewed distribution were expressed 
as medians with lower and upper quartiles, and they were 
log transformed in order to normalise their distribution. The 
categorical variables were expressed as numbers with percent-
ages. The inter-group differences were tested using the c2 test. 
Relationships between variables were assessed using 
Pearson’s (r) or standardised (b) correlation coefficients in uni-
variate linear regression models, and if they were statistically 
significant they were included in multivariate models. Scores 
in MHLC as well as in GSES were used as dependent vari-
ables. As depression (assessed using a questionnaire) was re-
lated to ‘internal control’, ‘external control (by chance)’, and 
self-efficacy, models for those variables were built with, as 
well as without, the BDI score included, in order to verify the 
relations between clinical and psychological variables with 
and without an adjustment for the BDI score. P < 0.05 was 
considered statistically significant.
RESULTS
A total of 758 patients with systolic HF were recruited among 
11 cardiology centres in Poland. The majority of them were 
inpatients (82%), males (79%), aged 64 ± 11 years old. 60% 
were classified in NYHA II–III, with reduced ejection fraction 
(mean LVEF 31 ± 9%). Sixty-one of them had an ischaemic 
HF aetiology. All patients received standard pharmacotherapy 
(i.e. 90% received ACEI and/or ARB, 69% received aldosterone 
antagonists, whereas 96% were treated with beta-blockers). 
Baseline, detailed characteristics of all examined patients are 
presented in Table 1.   
There were the following mean scores (with SD) obtained 
by patients with HF: 26 ± 5 for ‘internal control’, 28 ± 5 for 
‘external control (by the others)’, and 22 ± 6 for ‘external 
control (by chance)’. The vast majority of patients perceived 
the ‘external control (by the others)’ and ‘internal control’ of 
their health as high (77% and 63%, respectively) or moder-
ate (22% and 36%, respectively) (Fig. 1). The MHLC scores 
are not focused around mean values, but are shifted towards 
scores above the mean, especially in the context of ‘external 
control (by the others)’ and ‘internal control’. Indeed, more 
than 25% of patients perceived their ‘internal control’ as 
‘high’, which was accompanied by a perception of both types 
of external localisation of health control also as ‘high’. Almost 
24% of them presented ‘high internal control’ accompanied by 
‘high external control (by the others)’ and ‘moderate external 
control (by chance)’. Less than 10% of patients demonstrated 
scores reflecting a ‘moderate’ level of all three localisations of 
health control, and none of them demonstrated low scores in 
all three MHLC subscales.
There were only a few weak associations between the 
localisation of health control and clinical variables (Table 2), and 
the majority of them did not remain significant after adjustment 
for BDI (except for the ‘internal control’, which was higher 
in patients taking statins, even after the adjustment for BDI) 
(p < 0.05). In general, ‘internal control’ was negatively, whereas 
‘external control (by chance)’ was positively related to BDI total 
score (p < 0.01) (Table 2). ‘External control (by the others)’ was 
not related to depression, and in the multivariable model it was 
positively related to the patients age, taking thiazide diuretics, 
and having an implanted device (all p < 0.05, Table 2).  
Mean score (with SD) for GSES obtained by all patients 
was 31 ± 5 points. The vast majority of patients estimated their 
self-efficacy as high or moderate (63% and 27%, respectively). 
In the multivariable model, the subjective perception of 
self-efficacy was not related to clinical variables; however, 
it was inversely associated with BDI (p < 0.001) (Table 2). 
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Self-efficacy was related to ‘internal control’ (r = 0.29) 
and ‘external control (by the others)’ (both p < 0.05) but not 
to ‘external control (by chance)’ (p > 0.05). There were no dif-
ferences in the strength of the aforementioned associations in 
other pre-specified subgroups of patients, as shown in Table 3. 
DISCUSSION
In the present study, we have shown that the majority of 
examined patients with HF placed themselves on the highest 
(or at least moderately high) level of all three types of health 
control. Importantly, no one placed him or herself at the 
lowest level of both ‘internal’ and/or ‘external control (by the 
others)’. This suggests that patients with systolic HF perceive 
the level of ‘external control (by the others)’ and ‘internal 
control’ of their health (as well as their subjective feeling of 
self-efficacy) as particularly high. Based on such results we 
can conclude that the majority of examined patients believe 
that their health is strongly dependent on the decisions and/or 
actions performed by other people, including healthcare 
professionals. Moreover, they also acknowledge a strong 
feeling of their own influence on their health and their high 
effectiveness in reaching any desired goals (including those 
related to health). 
The pattern of these psychological features appears to 
be different from those seen in patients with other chronic 
diseases (for instance, diabetes [2], epilepsy [14]).
The pattern of the subjective perception of health control 
observed in our study was homogenous across the whole spec-
trum of the HF cohort; there were practically no relations with 
either HF severity, HF duration, the presence of co-morbidities, 
or the applied treatment, except for the relation between 
‘internal control’ and taking statins and the relation between 
‘external control (by the others)’ and taking diuretics, as well 
as having an implanted device. Although the relations between 
the scores in MHLC subscales and particular medications are 
hard to explain, the fact that patients having implanted devices 
were characterised by higher levels of ‘external control (by the 
others)’ seems to be reasonable from the psychological point 
of view. The experience of the reduction of symptoms (e.g. 
resulting from having cardiac resynchronisation therapy) may 
be linked to the conviction about the role of physicians in 
the patients’ health status. On the other hand, it is very prob-
able that each patient who actually has an implanted device 
believed in the physician’s role before they agreed to have 
the implantation, as this procedure requires entrusting one’s 
life and health to healthcare professionals, which is related to 
the perception of high ‘external control (by the others)’ [15]. 
The presented results also confirmed previous findings, 
suggesting that depressive symptoms are inversely related to 
‘internal control’ and positively related to ‘external control 
(by chance)’ [16].
Scores in GSES were also independent from the clinical 
characteristics of the examined patients. It is surprising be-
cause it is known that the sense of self-efficacy is related to 
self-reported physical functioning and to the severity of the 
disease (e.g. in patients with chronic obstructive pulmonary 
disease and HF [17]). Self-efficacy is also known as an im-
portant predictor of emotional and psychosocial adjustment 
of patients with epilepsy [18].
The subjective perception of self-efficacy was inversely 
related to depressive symptoms, which is consistent with the 
majority of previous findings [19]. We have also observed 
relations between particular localisations of health control 
and the sense of self-efficacy, which is also consistent with 
the results of studies conducted previously [20]. 
Figure 1. The distribution of 758 patients with systolic heart 
failure, according to their subjective perception of internal 
control, external control (by the others), and external control 
(by chance) using scores obtained with the Multidimensional 
Health Locus of Control Scale (categorised as low, moderated, 
or high scores, as defined within the ‘Methods’ section)
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Limitations of the study
As there are psychological differences between patients who 
agree vs. disagree to participate in this type of a study, so our 
results may be biased and should not be generalised beyond 
the studied group. 
CONCLUSIONS AND CLINICAL IMPLICATIONS 
The presented results indicate that patients with systolic HF 
are convinced that they control their own health and that 
their activities are efficient. Perhaps healthcare profession-
als should give patients more opportunities to take care of 
themselves in the process of HF management. Moreover, it 
appears that patients with systolic HF are conscious about the 
role of others (including healthcare providers). Healthcare 
professionals should consider this information in their clinical 
practice because it is in favour of implementation of a part-
nership model of specialists’ care of patients with HF. Such 
observations should be taken into account while designing 
any type of initiatives aimed at helping patients with HF in 
their everyday management. 
What is particularly important from a practical point of 
view is that it has been shown that the localisation of health 
control is crucial in the context of adherence to medical treat-
ment. This conclusion was made based on numerous studies 
involving patients with other chronic diseases, like: diabetes 
[2], hypertension [3], hypercholesterolaemia [4], and schizo-
phrenia [21] as well as patients treated using haemodialysis 
[22]. Moreover, it has been demonstrated that the modulation 
of beliefs regarding health control [23] as well as the level of 
self-efficacy [19] can reduce depressive symptoms, which 
are very common in patients with HF. There is also evidence 
suggesting that there is a link between locus of health control 
and survival in patients after lung transplantation (i.e. patients 
with ‘internal control’ lived significantly longer [24]). 
To summarise, we suggest that the patient’s socio-emo-
tional state (e.g. in terms of health control beliefs and the sense 
of self-efficacy) should be assessed as part of a multidimen-
sional approach towards HF patients, which is suggested by 
current guidelines related to the management of HF. 
The project was funded by Wroclaw Medical University 
(a statutory activities of Laboratory for Applied Research on 
Cardiovascular System, ST-722).
Conflict of interest: none declared
Table 3. Associations between the scale scores reflecting the localisation of health control and self-efficacy in selected subgroups 
of 758 patients with systolic heart failure (HF)
Analyses were performed  
in the following subgroups  
of patients with systolic HF
N GSES  
vs. internal control
GSES vs. external  
control (by the others)
GSES vs. external  
control (by chance)
All 758 0.29*** 0.09* 0.03
Men 599 0.28*** 0.09* 0.04
Women 159 0.32*** 0.10 –0.002
Inpatients 624 0.28*** 0.06 0.01
Outpatients 134 0.30*** 0.22* 0.10
Age ≤ 64 years (median) 392 0.26*** 0.11** –0.02
Age > 64 years 366 0.32*** 0.09 0.07
NYHA class: I and II 449 0.29*** 0.11* 0.04
NYHA class: III and IV 309 0.28*** 0.08 0.03
HF aetiology: CAD 460 0.03*** 0.06 0.01
HF aetiology: non-CAD 298 0.27*** 0.15** 0.05
< 3 co-morbidities 355 0.30*** 0.13* 0.05
≥ 3 co-morbidities 403 0.28*** 0.07 0.02
With any device 365 0.32*** 0.13* 0.01
Without any device 393 0.26*** 0.07 0.05
< 5 medications 200 0.27*** 0.06 –0.05
≥ 5 medications (median) 558 0.30*** 0.10* 0.05
BDI score ≥ 14 points #  225 0.24*** 0.12 0.12
BDI score < 14 points #  533 0.26*** 0.06 0.007
Results are presented as Pearson’s linear correlation coefficients (r); *p < 0.05; **p < 0.01; ***p > 0.001 reflect a statistical significance of the 
correlation coefficients; # Depression was defined as BDI score ≥ 14 points; GSES — Generalised Self Efficacy Scale; NYHA — New York Heart 
Association; CAD — coronary artery disease; BDI — Beck Depression Inventory
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S t r e s z c z e n i e
Wstęp: Umiejscowienie kontroli zdrowia i poczucie skuteczności to zmienne, które nie zostały dokładnie przebadane wśród 
chorych z niewydolnością serca (HF), mimo że te cechy psychologiczne mogą determinować stosunek pacjenta do personelu 
medycznego, a także realizowanie zaleceń lekarskich.
Metody: Do prospektywnego polskiego badania wieloośrodkowego Caps-Lock-HF włączono 758 osób ze skurczową HF (wiek: 
64 ± 11 lat, mężczyźni: 79%, klasy NYHA III–IV: 40%, etiologia niedokrwienna: 61%). Umiejscowienie kontroli zdrowia 
oceniano za pomocą skali MHLC, wyróżniającej 3 wymiary (kontrolę wewnętrzną, zewnętrzną podkreślającą wpływ innych, 
zewnętrzną podkreślającą wpływ przypadku). Skala GSES została użyta do oceny poczucia skuteczności, a Inwentarz Depresji 
Becka (BDI) — do oceny nasilenia objawów depresyjnych.
Wyniki: Większość badanych oceniła kontrolę zdrowia opartą na wpływie innych, jak również własny wpływ na zdrowie jako 
wysokie (odpowiednio 77% i 63%) lub przynajmniej umiarkowane (22% i 36%); poczucie skuteczności było również wysokie 
lub umiarkowane (63% i 27%). Co ważne, było to niezależne od stopnia zaawansowania HF, czasu trwania choroby, obecności 
schorzeń towarzyszących i stosowanej terapii. Im silniejsze było poczucie własnego wpływu na zdrowie, tym silniejsze poczu-
cie skuteczności (p < 0,05), a obie te cechy były odwrotnie proporcjonalne do nasilenia objawów depresyjnych (p < 0,05). 
Wnioski: Zbadana konfiguracja cech psychologicznych: poczucie kontroli zdrowia i poczucie skuteczności sugerują, że pa-
cjenci z HF są w stanie doceniać wpływ innych osób (w tym lekarzy), jak również siebie samych na przebieg choroby oraz są 
przekonani o skuteczności swoich działań. Takie wyniki wskazują, że warto rozważyć wprowadzenie partnerskiego modelu 
opieki medycznej w leczeniu przewlekłej, skurczowej HF.
Słowa kluczowe: niewydolność serca, cechy psychologiczne, umiejscowienie kontroli zdrowia, poczucie skuteczności
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